Skip to main content

OXIDO NITRICO EN LA SALUD CARDIOPULMONAR: INTEGRACION DE IMAGENES, IA Y CONOCIMIENTOS SOBRE LA MICROBIOTA PARA LA MEDICINA DE PRECISION EN HIPERTENSION PULMONAR

PID2024-155807OB-C21

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para la Investigación y el Desarrollo Experimental
Subprogram Subprograma Estatal de Generación de Conocimiento Científico-Técnico y Desarrollo Experimental
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2024
State Plan 2024-2027 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre ASOCIACIÓN CENTRO DE INVESTIGACION COOP. BIOMATERIALES

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Docta Complutense
Publication Artículo científico (JournalArticle)

Pulmonary surfactant nanoparticles for lung‐targeted and dose‐efficient delivery

  • Fernández Méndez, Laura
  • Piñol Cancer, Marina
  • Souto Riobó, Itziar
  • Urkola Arsuaga, Ainhize
  • González Lozano, Elena
  • Fernández Folgueral, Irene
  • de Alejo, Claudia Miranda Pérez
  • Azkargorta, Mikel
  • Elortza, Felix
  • Tagliaferro Quiñonero, Alberto
  • Silvio, Desire Di
  • Cañadas Benito, Olga
  • Maiz, Jon
  • Pérez Gil, Jesús
  • Ramos Cabrer, Pedro
  • Ruíz Cabello, Jesús
  • Carregal Romero, Susana
Although pulmonary drug delivery enables lung-targeted therapy, its clinical efficacy is often limited by inflammation, heterogeneous deposition, and physiological barriers such as mucociliary clearance and phagocytic uptake. Here, we report a biomimetic platform based on pulmonary surfactant nanoparticles (PSNPs) that preserves native surfactant proteins and biophysical functionality, resulting in enhanced pulmonary delivery. Microfluidic synthesis yielded highly uniform PSNPs with improved encapsulation efficiency and colloidal stability, while markedly increasing surfactant protein retention from 33% using conventional extrusion to 95% via microfluidics, corresponding to a 2.4-fold improvement. Functionally, PSNPs exhibited superior interfacial activity compared to lipid-only liposomes, increasing surface pressure from 5–10 mN/m to 25–30 mN/m, and achieved an approximately 80-fold enhancement in alveolar cellular uptake. In vitro, nintedanib-loaded PSNPs significantly reduced fibroblast migration, proliferation, collagen deposition, and TGF-β secretion relative to free drug and control formulations. In vivo, PSNPs demonstrated high pulmonary retention (95% injected dose per gram of lung tissue), efficient penetration into fibrotic regions, and minimal off-target accumulation in the liver (0.5%). Therapeutic efficacy was confirmed in a bleomycin-induced pulmonary fibrosis model, where PSNPs improved lung function and restored tissue architecture at doses as low as 0.5 mg/kg. Collectively, these results establish PSNPs as a robust lung-targeted nanotherapeutic platform, where microfluidic synthesis enables enhanced biomimicry, improved protein preservation, and superior therapeutic performance compared to conventional fabrication methods.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Iron Oxide Nanoparticles for Ligand-Mediated Targeted Imaging

  • Miranda-Pérez de Alejo, Claudia
  • Miguel-Coello, Ana B.
  • Piñol-Cancer, Marina
  • Urkola-Arsuaga, Ainhize
  • Martínez-Parra, Lydia
  • Carrillo-Romero, Juliana
  • Fernández-Méndez, Laura
  • Goñi-de-Cerio, Felipe
  • Herranz, Fernando
  • Silvio, Desire di
  • Gallego, Marta
  • Sierra-Serrano, Beatriz
  • Cardo, Lucia
  • Carregal-Romero, Susana
  • Ruiz-Cabello, Jesús
Superparamagnetic iron oxide nanoparticles (SPIONs) are widely employed as platforms for ligand-mediated targeting in multimodal imaging and targeted therapeutic applications owing to their intrinsic magnetic properties and versatility for surface and core modification. In addition to magnetic resonance imaging contrast, SPIONs can be labeled with radioisotopes incorporated into the crystalline structure or functionalized with chemically bound dyes or chelating agents, enabling complementary imaging modalities such as fluorescence imaging and positron emission tomography. However, chemical functionalization of nanoparticles with targeting ligands can induce alterations not only in their physicochemical properties but also in their interactions with biological systems. These nano-biointeractions are critical determinants of biological performance and must be carefully evaluated. In this study, we investigate the impact of ligand functionalization on SPION-cancer cell interactions to elucidate key parameters relevant to the successful clinical translation of nanomedicine-based targeted imaging agents., SCR acknowledges the Ramón Areces Foundation (CIVP21S13151),the MCIN/AEI 10.13039/501100011033 projects (PID2022-142842OB-I00,CNS2023-143944, RYC2020-030241-I), the Eusko Jaurlaritza projects(PIBA_2025_1_0057) and the Diputación Foral de Gipuzkoa (2025-CIE4-000041-01). JRC is funded by the MCIN/AEI/10.13039/501100011033(PID2021-123238OB-I00 and PID2024-155807OB-C21), the Eusko Jaurlar-itza under the Elkartek 2024 and 2025 Programs (KK-2024-00041, bmG24,and KK-20205-00084, TERACARD, respectively), and R&D projects in Health (Grant number 2022333041). SCR and JRC thank IKERBASQUE for their sponsorships. We also acknowledge the “Fundación contra la hipertensión pulmonar” for funding (Empathy)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

NLRP3 haploinsufficiency unmasks a compensatory NLRP1-NLRP3 interaction that drives accelerated aging in mice

  • Muela-Zarzuela, Inés
  • Alcocer-Gómez, Elisabet
  • Suarez-Rivero, Juan M.
  • Low, Evon
  • Ishaq, Abbas
  • Azkargorta, Mikel
  • Luque-Sierra, Amparo
  • Martin, Franz
  • Elortza, Félix
  • Astorga-Gamaza, Antonio
  • Antón, Rosa
  • Bali, Sofía
  • Tamargo-Azpilicueta, Joaquin
  • Guerra-Castellano, Alejandra
  • Díaz-Moreno, Irene
  • Joachimiak, Lukasz A.
  • Oroz, Javier
  • Ruiz-Cabello, Jesús
  • von Zglinicki, Thomas
  • Sanz, Alberto
  • Cordero, Mario D.
The NLRP3 inflammasome has been implicated in a wide range of human diseases, including cardiovascular, metabolic, neurodegenerative (such as Alzheimer's disease), and other age-related conditions. This has positioned NLRP3 as a promising pharmacological target. Numerous studies have shown that complete NLRP3 ablation can prevent or mitigate these diseases. However, total elimination of NLRP3 is not a feasible therapeutic strategy for the millions of patients affected by these degenerative disorders. Consequently, drug development efforts have focused on partial inhibition of NLRP3 using compounds that reduce its expression or activity. Paradoxically, although many studies have used Nlrp3 knockout mouse models, Nlrp3 haploinsufficient mice-more representative of the effects of pharmacological inhibition-are rarely included and remain poorly characterized. Here, we report the long-term effects of Nlrp3 haploinsufficiency during aging. Although no overt differences were observed in early life, by 16 months of age, Nlrp3 heterozygous mice exhibited signs of accelerated inflammatory aging, driven by compensatory overexpression of NLRP1. Mechanistic studies provide evidence of a previously unidentified interaction between NLRP1 and NLRP3, forming a hybrid inflammasome that drives NLRP1-mediated inflammatory overactivation when NLRP3 expression is reduced. Accordingly, anti-inflammatory treatment provided notable but moderate improvement of the inflammatory phenotype, whereas genetic inhibition of Nlrp1 more consistently reduced inflammation and extended health span. Our findings reveal a previously unidentified compensatory interaction between NLRP1 and NLRP3 and suggest that multiinflammasome inhibition may offer a more effective strategy for treating aging and age-related diseases., This study was supported by grant PI21/01656 from the Instituto de Salud Carlos III (Spain), grant EMC21_00033 from the EMERGIA programme of the Junta de Andalucía, and grant CNS2024-154939 from the Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación. Funding for open access publication was provided by the Universidad Pablo de Olavide/CBUA. J.R.-C . is funded by grant PID2021-123238OB- I00 and PID2024-155807OB- C 21 funded by the MCIN/AEI and from the Fundación contra la Hipertensión Pulmonar (Project Empathy). I.D.-M. is funded by grant PID2024-157414NB- I00 funded by the MICIU/AEI/10.13039/501100011033 and by ERDF/EU, Ramon Areces Foundation (LEUCYTO-FRA2025- MAR), grant FPU22/01094 funded by MICIU/AEI/10.13039/501100011033 and by ESF+ to J.T.-A., and grant PTQ2024-013941 funded by MICIU/AEI/10.13039/501100011033 to A.G.-C . J.O. is supported by the grants PID2019-109276RA- I00 and PID2022-142382OB- I00 funded by MCIN/AEI/10.13039/501100011033 and by FEDER A way to make Europe and by donations from the Spanish and Mexican Ondine Associations. J.O. was a recipient of a Leonardo Grant from the Spanish BBVA Foundation (BBM_TRA_0203) and a Ramón y Cajal Fellow of the Spanish AEI-Ministry of Science and Innovation (RYC2018-026042- I funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future”)., Peer reviewed